Chicago IL 2型糖尿病临床试验
19项针对 2型糖尿病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Cedar Crosse Research Center, Chicago
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中欢迎健康志愿者
- Northwestern University, Chicago
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
招募中3 期
- Cedar Crosse Research Center, Chicago
- Northwestern University, Chicago
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, Chicago
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
招募中2 期
- AES - DRS - Synexus Clinical Research US, Inc. - Chicago, Chicago
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- Cedar-Crosse Research Center, Chicago
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- Research by Design, LLC - Internal Medicine, Chicago
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Chicago Clinical Research Institute, Chicago
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
招募中3 期
- Research Site, Chicago
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
招募中3 期
- Research Site, Chicago
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
招募中1 期欢迎健康志愿者
- Research Site, Chicago
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
招募中3 期
- University of Illinois at Chicago, Chicago
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
招募中
- Northwestern University, Chicago
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
招募中
- Northwestern University, Chicago
Achieving Routine Intervention and Screening for Emotional Health
招募中
- University of Chicago, Chicago
Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes
招募中观察性研究
- Illinois Institute of Technology, Chicago
Enhancing Diabetes Care: Exposome &Amp; Sensors
招募中观察性研究
- University of Illinois - Chicago, Chicago
- University of Illinois College of Nursing, Chicago
My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes
招募中欢迎健康志愿者
- University of Illinois at Chicago, Chicago
其他城市的 2型糖尿病试验
- San Antonio, TX37 项研究
- Houston, TX31 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Miami, FL19 项研究
- Dallas, TX19 项研究
- Columbus, OH18 项研究
- Las Vegas, NV18 项研究
- Atlanta, GA17 项研究
- San Diego, CA17 项研究
- Los Angeles, CA16 项研究
- New York City, NY16 项研究
Chicago的其他研究
- 非小细胞肺癌61 项研究
- 乳腺癌58 项研究
- 癌症（所有类型）51 项研究
- 转移性癌症45 项研究
- 前列腺癌45 项研究
- 肥胖症41 项研究
- 肺癌41 项研究
- 卵巢癌36 项研究
- 卒中34 项研究
- 结直肠癌33 项研究
- 心力衰竭31 项研究
- 超重28 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。